Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
United States
100%
Epidemiology
100%
Population Analysis
100%
Nasopharyngeal Lymphoma
100%
Overall Survival
80%
Radiation Therapy
80%
Disease-specific Survival
60%
Histological Subtypes
40%
NKT Cells
40%
T-cell non-Hodgkin Lymphoma
40%
Surveillance Epidemiology
40%
Ann Arbor Stage
40%
Retrospective Cohort Study
20%
Multivariate Analysis
20%
Age at Diagnosis
20%
Young Age
20%
Patient Survival
20%
Median Overall Survival
20%
Advanced Age
20%
End Results Database
20%
National Database
20%
Patient Data
20%
B-cell non-Hodgkin Lymphoma (B-NHL)
20%
Prognosticator
20%
Histopathology
20%
Survival Trends
20%
Lymphoma Subtypes
20%
Extranodal Natural killer/T-cell Lymphoma
20%
Medicine and Dentistry
Cohort Effect
100%
Overall Survival
100%
Radiation Therapy
80%
Non-Hodgkin Lymphoma
60%
Disease Specific Survival
60%
Natural Killer T Cell
40%
Surveillance, Epidemiology, and End Results
40%
Retrospective Cohort Study
20%
Histopathology
20%
B Cell
20%
NK T Cell Lymphoma
20%
Patient-Data
20%
Multivariate Analysis
20%